The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug resistant tuberculosis in India and China
The health and economic benefits possible with novel tuberculosis vaccines – A modeling study in India and Indonesia
Population-level health and economic impacts of introducing Vaccae vaccination in China: a modelling study
Meeting the 2030 End TB goals in the wake of COVID-19: a modelling study of countries in the USAID TB portfolio.
